Trials / Conditions / Progesterone Receptor Positive Tumor

Progesterone Receptor Positive Tumor

8 registered clinical trials studyying Progesterone Receptor Positive Tumor.

Status	Trial	Sponsor	Phase
Completed	Study of Tamoxifen in Well Differentiated Neuroendocrine Tumors and Hormone Receptor Positive Expression NCT03870399	AC Camargo Cancer Center	Phase 2
Active Not Recruiting	A Text-based Intervention in Improving Adherence to Hormone Therapy in Patients With Stage I-III Hormone Recep NCT04086875	Thomas Jefferson University	N/A
Completed	Palbociclib in Combination With Tamoxifen as First Line Therapy for Metastatic Hormone Receptor Positive Breas NCT02668666	Oana Danciu, MD	Phase 2
Active Not Recruiting	Neoadjuvant Pembrolizumab + Decitabine Followed by Std Neoadj Chemo for Locally Advanced HER2- Breast Ca NCT02957968	Virginia Commonwealth University	Phase 2
Terminated	A Phase II Study Evaluating the Role of Androgen Receptors as Targets for Therapy of Pre-treated Post-menopaus NCT02000375	Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS	Phase 2
Terminated	A Randomised Study of Docosahexaenoic Acid (DHA) in Metastatic Breast Cancer NCT01548534	University Hospital, Tours	Phase 3
Completed	Pilot Study Estradiol Followed by Exemestane Hormone Receptor + Metastatic Breast Cancer NCT01385280	University of Arizona	N/A
Completed	Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating NCT00066690	ETOP IBCSG Partners Foundation	Phase 3